Celsion Corp (CLSN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
October 2018
74
About the Report
About the Report
Summary
Celsion Corp (Celsion) is an oncology company that strives to develop a portfolio of new cancer treatments, including directed chemotherapies, RNA or DNA based therapies and immunotherapies. The company's three platform technologies including Lysolipid Thermally Sensitive Liposomes (LTSL), TheraPlas and TheraSilence provide the foundation for a wide range of treatments for common and difficult-to-treat forms of cancers. Its lead product candidate ThermoDox is a proprietary form of doxorubicin based LTSL technology in a Phase III clinical trial for the treatment of non-resectable hepatocellular carcinoma (HCC) and a Phase II clinical trial for recurrent chest wall (RCW) breast cancer. It is also developing a comprehensive pipeline of targeted therapeutic agents. Celsion is headquartered in Lawrenceville, New Jersey, the US.
Celsion Corp (CLSN)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Celsion Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Celsion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Celsion Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Celsion Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Celsion Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Celsion Corp, Medical Devices Deals, 2012 to YTD 2018 10
Celsion Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Celsion Corp, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Celsion Enters into Partnership with Children's Research Institute 13
Celsion Enters into Agreement with Zhejiang Hisun Pharma 14
Celsion Expands Technology Development Agreement With Zhejiang Hisun Pharma 15
Celsion Enters Into Technology Development Agreement With Zhejiang Hisun Pharma For ThermoDox 16
Equity Offering 18
Celsion Plans to Raise up to USD75.5 Million in Public Offering of Securities 18
Celsion to Raise USD15 Million in Public Offering of Shares 19
Celsion to Raise up to USD10 Million in Public Offering of Shares 20
Celsion Plans to Raise up to USD7.4 Million in Private Placement of Shares up on Exercise of Warrants 21
Celsion Raises USD6.6 Million in Public Offering of Shares 22
Celsion Plans to Raise Funds through Private Placement of Shares up on Exercise of Warrants 23
Celsion Raises USD4.2 Million in Private Placement of Shares and Warrants 24
Celsion to Raise up to USD2.4 Million in Public Offering of Shares 26
Celsion Raises Funds through Private Placement of Shares upon Exercise of Warrants 27
Celsion Raises USD0.6 Million in Private Placement of Shares upon Exercise of Warrants 28
Celsion Raises USD0.1 Million in Private Placement of Shares upon Exercise of Warrants 29
Celsion Raises USD5 Million in Public Offering of Shares and Warrants 30
Celsion Raises USD1.8 Million in Private Placement of Shares and Warrants 31
Celsion Plans to Raise USD12.3 Million in Private Placement of Shares upon Exercise of Warrants 32
Celsion Raises Funds through Private Placement of Shares up on Exercise of Warrants 33
Celsion Raises USD6 Million in Private Placement of Shares 34
Celsion Raises USD8 Million in Private Placement of Shares 35
Celsion Raises USD15 Million in Private Placement Of Common Stock 36
Celsion Raises USD9.8 Million in Private Placement of Shares 37
Celsion Completes Private Placement Of Shares For USD 15 Million 38
Celsion Completes Public Offering Of Common Stock For USD 7 Million 39
Acquisition 40
Celsion Completes Acquisition of Egen Biopharma Company 40
Celsion Explores Acquisition Opportunities 42
Celsion Corp-Key Competitors 43
Celsion Corp-Key Employees 44
Celsion Corp-Locations And Subsidiaries 45
Head Office 45
Recent Developments 46
Financial Announcements 46
Aug 14, 2018: Celsion announces second quarter 2018 financial results 46
May 11, 2018: Celsion Reports First Quarter 2018 Financial Results and Provides Business Update 49
Mar 27, 2018: Celsion Announces Fourth Quarter And Full-Year 2017 Financial Results 52
Nov 14, 2017: Celsion Reports Third Quarter 2017 Financial Results and Provides Business Update 55
Aug 15, 2017: Celsion Reports Second Quarter 2017 Financial Results and Provides Business Update 58
May 12, 2017: Celsion Reports First Quarter 2017 Financial Results and Provides Business Update 61
Mar 16, 2017: Celsion Reports Year End 2016 Financial Results and Provides Business Update 63
Corporate Communications 65
Jun 25, 2018: Celsion to join Russell Microcap Index 65
Jun 14, 2018: Celsion regains compliance with NASDAQ listing requirements 66
Aug 04, 2017: Celsion to Delist from the Tel Aviv Stock Exchange 67
Other Significant Developments 68
Jul 11, 2018: Horizon Technology Finance provides investment portfolio update 68
Jan 18, 2018: Celsion Provides Corporate Update and 2018 Outlook 70
Appendix 74
Methodology 74
About GlobalData 74
Contact Us 74
Disclaimer 74
List of Figure
List of Figures
Celsion Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Celsion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Celsion Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Celsion Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Celsion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Celsion Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Celsion Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Celsion Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Celsion Corp, Medical Devices Deals, 2012 to YTD 2018 10
List of Table
List of Tables
Celsion Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Celsion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Celsion Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Celsion Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Celsion Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Celsion Corp, Medical Devices Deals, 2012 to YTD 2018 10
Celsion Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Celsion Enters into Partnership with Children's Research Institute 13
Celsion Enters into Agreement with Zhejiang Hisun Pharma 14
Celsion Expands Technology Development Agreement With Zhejiang Hisun Pharma 15
Celsion Enters Into Technology Development Agreement With Zhejiang Hisun Pharma For ThermoDox 16
Celsion Plans to Raise up to USD75.5 Million in Public Offering of Securities 18
Celsion to Raise USD15 Million in Public Offering of Shares 19
Celsion to Raise up to USD10 Million in Public Offering of Shares 20
Celsion Plans to Raise up to USD7.4 Million in Private Placement of Shares up on Exercise of Warrants 21
Celsion Raises USD6.6 Million in Public Offering of Shares 22
Celsion Plans to Raise Funds through Private Placement of Shares up on Exercise of Warrants 23
Celsion Raises USD4.2 Million in Private Placement of Shares and Warrants 24
Celsion to Raise up to USD2.4 Million in Public Offering of Shares 26
Celsion Raises Funds through Private Placement of Shares upon Exercise of Warrants 27
Celsion Raises USD0.6 Million in Private Placement of Shares upon Exercise of Warrants 28
Celsion Raises USD0.1 Million in Private Placement of Shares upon Exercise of Warrants 29
Celsion Raises USD5 Million in Public Offering of Shares and Warrants 30
Celsion Raises USD1.8 Million in Private Placement of Shares and Warrants 31
Celsion Plans to Raise USD12.3 Million in Private Placement of Shares upon Exercise of Warrants 32
Celsion Raises Funds through Private Placement of Shares up on Exercise of Warrants 33
Celsion Raises USD6 Million in Private Placement of Shares 34
Celsion Raises USD8 Million in Private Placement of Shares 35
Celsion Raises USD15 Million in Private Placement Of Common Stock 36
Celsion Raises USD9.8 Million in Private Placement of Shares 37
Celsion Completes Private Placement Of Shares For USD 15 Million 38
Celsion Completes Public Offering Of Common Stock For USD 7 Million 39
Celsion Completes Acquisition of Egen Biopharma Company 40
Celsion Explores Acquisition Opportunities 42
Celsion Corp, Key Competitors 43
Celsion Corp, Key Employees 44
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.